摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-Dipyridin-3-yl-1,3-thiazole

中文名称
——
中文别名
——
英文名称
2,4-Dipyridin-3-yl-1,3-thiazole
英文别名
——
2,4-Dipyridin-3-yl-1,3-thiazole化学式
CAS
——
化学式
C13H9N3S
mdl
——
分子量
239.3
InChiKey
ITJUUTBLPGKSOG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    66.9
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • POTENT AND SELECTIVE INHIBITORS OF CYTOCHROME P450
    申请人:University of Kentucky Research Foundation
    公开号:US20210246109A1
    公开(公告)日:2021-08-12
    Inhibitors of the enzyme cytochrome P450 (CYP), including 1B1 (CYP1B1), 1A1 (CYP1A1) and 19A1 (CYP19A1) are provided, and are useful in medical applications. Disclosed are highly potent and selective compounds that can be used in chemoprevention to ameliorate malignant changes induced by CYP, or to aid in treatment, including restoration of chemotherapeutic efficacy.
    本文提供了细胞色素P450 (CYP) 酶的抑制剂,包括1B1 (CYP1B1),1A1 (CYP1A1) 和19A1 (CYP19A1),这些抑制剂在医学应用中非常有用。本文还披露了高效、选择性的化合物,可用于化学预防,以减轻CYP引起的恶性变化,或用于治疗,包括恢复化疗的疗效。
  • ACTIVE OXYGEN INHIBITOR
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP0513387A1
    公开(公告)日:1992-11-19
    An active oxygen inhibitor which contains an azole derivative represented by general formula (1) or a salt thereof as the active ingredient, wherein R¹ represents phenyl which may be substituted by 1 to 3 lower alkoxy groups or by a lower alkyleneoxy group, etc.; R² represents hydrogen, phenyl, halogen, lower alkoxycarbonyl, lower alkyl, lower aminoalkyl which may be substituted by lower alkyl, dihydrocarbostyrilyl, etc.; R³ represents the group (α), wherein R4B represents hydroxy, carboxy, lower alkenyl or lower alkyl, and m represents 0, 1 or 2; and X represents sulfur or oxygen.
    R²代表氢、苯基、卤素、低级烷氧基羰基、低级烷基、可被低级烷基取代的低级基烷基、二氢羧基等;R³代表基团(α),其中 R4B 代表羟基、羧基、低级烯基或低级烷基,m 代表 0、1 或 2;X 代表或氧。
  • Azole derivatives and their use as superoxide radical inhibitors
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP1130017A2
    公开(公告)日:2001-09-05
    A superoxide radical inhibitor containing, as an effective ingredient, an azole derivative represented by the general formula (1), [wherein R1 represents a phenyl group which may have 1-3 lower alkoxy groups as substituent(s) on the phenyl ring, a phenyl group having a lower alkylenedioxy group, or the like; R2 represents a hydrogen atom, a phenyl group, a halogen atom, a lower alkoxycarbonyl group, a lower alkyl group, an amino-lower alkyl group which may have a lower alkyl group as a substituent, a dihydrocarbostyril group, or the like; R3 represents a group of the formula, (R4B represents a hydroxyl group, a carboxy group, a lower alkenyl group or a lower alkyl group. m represents 0, 1 or 2); X represents a sulfur atom : ] or a salt thereof.
    一种超氧自由基抑制剂,其有效成分含有通式(1)代表的唑衍生物、 [其中 R1 代表苯基,苯基环上可以有 1-3 个低级烷氧基作为取代基,苯基上可以有低级烷基二氧基等;R2 代表氢原子、苯基、卤素原子、低级烷氧基羰基、低级烷基、基低级烷基,基低级烷基上可以有低级烷基作为取代基,二氢羰基等;R3 代表式中的一个基团、 (R4B 代表羟基、羧基、低级烯基或低级烷基,m 代表 0、1 或 2); X 代表原子: ]或其盐。
  • Azole derivatives as superoxide radical inhibitor
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP0934937B1
    公开(公告)日:2002-02-27
  • US5643932A
    申请人:——
    公开号:US5643932A
    公开(公告)日:1997-07-01
查看更多